{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:37:00Z","timestamp":1790102220489,"version":"4.0.1"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,20]]},"DOI":"10.7759\/cureus.29367","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T12:18:37Z","timestamp":1663676317000},"source":"Crossref","is-referenced-by-count":32,"title":["Postmenopausal Osteoporosis: A Literature Review"],"prefix":"10.7759","author":[{"given":"Aayushi","family":"Bhatnagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya L","family":"Kekatpure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_438_17","article-title":"Prevalence of osteoporosis in apparently healthy adults above 40 years of age in Pune City, India","volume":"22","author":"Kadam NS","year":"2018","unstructured":"Kadam NS, Chiplonkar SA, Khadilkar AV, Khadilkar VV. Prevalence of osteoporosis in apparently healthy adults above 40 years of age in Pune City, India. Indian J Endocrinol Metab. 2018, 22:67-73. 10.4103\/ijem.IJEM_438_17","journal-title":"Indian J Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0976-7800.191012","article-title":"Age of menopause and determinants of menopause age: A PAN India survey by IMS","volume":"7","author":"Ahuja M","year":"2016","unstructured":"Ahuja M. Age of menopause and determinants of menopause age: A PAN India survey by IMS. J Midlife Health. 2016, 7:126-31. 10.4103\/0976-7800.191012","journal-title":"J Midlife Health"},{"key":"ref3","unstructured":"India - Sample registration system (SRS)-statistical report. (2019). Accessed. August 20, 2022: https:\/\/censusindia.gov.in\/nada\/index.php\/catalog\/40526."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/cmi.cmi_5_20","article-title":"Postmenopausal osteoporosis - an Indian perspective","volume":"18","author":"Rajan R","year":"2020","unstructured":"Rajan R, Paul J, Kapoor N, Cherian KE, Paul TV. Postmenopausal osteoporosis - an Indian perspective. Curr Med Issue. 2020, 18:98. 10.4103\/cmi.cmi_5_20","journal-title":"Curr Med Issue"},{"key":"ref5","article-title":"Osteoporosis","author":"Nayak NK","year":"2016","unstructured":"Nayak NK, Khedkar CC, Khedkar CD, Khedkar GD. Osteoporosis. Encyclopedia of Foods & Health. Caballero B, Finglas P, Toldr\u00e1 F (ed): Elsevier, Amsterdam, Netherlands; 2016. 1:181-5."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000489672","article-title":"Cortical or trabecular bone: what's the difference?","volume":"47","author":"Ott SM","year":"2018","unstructured":"Ott SM. Cortical or trabecular bone: what's the difference?. Am J Nephrol. 2018, 47:373-5. 10.1159\/000489672","journal-title":"Am J Nephrol"},{"key":"ref7","article-title":"Biological basis of bone strength: anatomy, physiology and measurement","volume":"20","author":"Hart NH","year":"2020","unstructured":"Hart NH, Newton RU, Tan J, Rantalainen T, Chivers P, Siafarikas A, Nimphius S. Biological basis of bone strength: anatomy, physiology and measurement. J Musculoskelet Neuronal Interact. 2020, 20:347-71.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-bioeng-062117-121139","article-title":"Bone mechanical properties in healthy and diseased states","volume":"20","author":"Morgan EF","year":"2018","unstructured":"Morgan EF, Unnikrisnan GU, Hussein AI. Bone mechanical properties in healthy and diseased states. Annu Rev Biomed Eng. 2018, 20:119-43. 10.1146\/annurev-bioeng-062117-121139","journal-title":"Annu Rev Biomed Eng"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1023\/b:abme.0000007797.92559.5e","article-title":"The toughness of cortical bone and its relationship with age","volume":"32","author":"Wang X","year":"2004","unstructured":"Wang X, Puram S. The toughness of cortical bone and its relationship with age. Ann Biomed Eng. 2004, 32:123-35. 10.1023\/b:abme.0000007797.92559.5e","journal-title":"Ann Biomed Eng"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9290(88)90132-7","article-title":"Composition of the cement line and its possible mechanical role as a local interface in human compact bone","volume":"21","author":"Burr DB","year":"1988","unstructured":"Burr DB, Schaffler MB, Frederickson RG. Composition of the cement line and its possible mechanical role as a local interface in human compact bone. J Biomech. 1988, 21:939-45. 10.1016\/0021-9290(88)90132-7","journal-title":"J Biomech"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of bone remodeling","volume":"6","author":"Feng X","year":"2011","unstructured":"Feng X, McDonald JM. Disorders of bone remodeling. Annu Rev Pathol. 2011, 6:121-45. 10.1146\/annurev-pathol-011110-130203","journal-title":"Annu Rev Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1115\/1.2895536","article-title":"A 20-year perspective on the mechanical properties of trabecular bone","volume":"115","author":"Keaveny TM","year":"1993","unstructured":"Keaveny TM, Hayes WC. A 20-year perspective on the mechanical properties of trabecular bone. J Biomech Eng. 1993, 115:534-42. 10.1115\/1.2895536","journal-title":"J Biomech Eng"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S54614","article-title":"The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil","volume":"10","author":"Baccaro LF","year":"2015","unstructured":"Baccaro LF, Conde DM, Costa-Paiva L, Pinto-Neto AM. The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil. Clin Interv Aging. 2015, 10:583-91. 10.2147\/CIA.S54614","journal-title":"Clin Interv Aging"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"NIH Consensus Development Panel","year":"2001","unstructured":"NIH Consensus Development Panel. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001, 285:785-95. 10.1001\/jama.285.6.785","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4065\/77.5.453","article-title":"Secondary causes of osteoporosis","volume":"77","author":"Fitzpatrick LA","year":"2002","unstructured":"Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc. 2002, 77:453-68. 10.4065\/77.5.453","journal-title":"Mayo Clin Proc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nm1096-1132","article-title":"Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta","volume":"2","author":"Hughes DE","year":"1996","unstructured":"Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med. 1996, 2:1132-6. 10.1038\/nm1096-1132","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0004563218759371","article-title":"The bone remodelling cycle","volume":"55","author":"Kenkre JS","year":"2018","unstructured":"Kenkre JS, Bassett J. The bone remodelling cycle. Ann Clin Biochem. 2018, 55:308-27. 10.1177\/0004563218759371","journal-title":"Ann Clin Biochem"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115628","article-title":"Re-thinking the bone remodeling cycle mechanism and the origin of bone loss","volume":"141","author":"Delaisse JM","year":"2020","unstructured":"Delaisse JM, Andersen TL, Kristensen HB, Jensen PR, Andreasen CM, S\u00f8e K. Re-thinking the bone remodeling cycle mechanism and the origin of bone loss. Bone. 2020, 141:115628. 10.1016\/j.bone.2020.115628","journal-title":"Bone"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2013.09.008","article-title":"Prevention and treatment of postmenopausal osteoporosis","volume":"142","author":"Tella SH","year":"2014","unstructured":"Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol. 2014, 142:155-70. 10.1016\/j.jsbmb.2013.09.008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s8756-3282(01)00642-1","article-title":"Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression","volume":"30","author":"Parfitt AM","year":"2002","unstructured":"Parfitt AM. Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone. 2002, 30:5-7. 10.1016\/s8756-3282(01)00642-1","journal-title":"Bone"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s8756-3282(01)00619-6","article-title":"Targeted and nontargeted remodeling","volume":"30","author":"Burr DB","year":"2002","unstructured":"Burr DB. Targeted and nontargeted remodeling. Bone. 2002, 30:2-4. 10.1016\/s8756-3282(01)00619-6","journal-title":"Bone"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000049","article-title":"The osteocyte: key player in regulating bone turnover","volume":"1","author":"Goldring SR","year":"2015","unstructured":"Goldring SR. The osteocyte: key player in regulating bone turnover. RMD Open. 2015, 1:e000049. 10.1136\/rmdopen-2015-000049","journal-title":"RMD Open"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-1915-z","article-title":"Osteocyte regulation of bone mineral: a little give and take","volume":"23","author":"Atkins GJ","year":"2012","unstructured":"Atkins GJ, Findlay DM. Osteocyte regulation of bone mineral: a little give and take. Osteoporos Int. 2012, 23:2067-79. 10.1007\/s00198-012-1915-z","journal-title":"Osteoporos Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(93)90235-3","article-title":"Increased intracortical remodeling following fatigue damage","volume":"14","author":"Mori S","year":"1993","unstructured":"Mori S, Burr DB. Increased intracortical remodeling following fatigue damage. Bone. 1993, 14:103-9. 10.1016\/8756-3282(93)90235-3","journal-title":"Bone"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040952","article-title":"Osteopetrosis","volume":"351","author":"Tolar J","year":"2004","unstructured":"Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med. 2004, 351:2839-49. 10.1056\/NEJMra040952","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(88)90191-7","article-title":"Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts","volume":"175","author":"Silver IA","year":"1988","unstructured":"Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res. 1988, 175:266-76. 10.1016\/0014-4827(88)90191-7","journal-title":"Exp Cell Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/jemt.10374","article-title":"Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities","volume":"61","author":"Delaiss\u00e9 JM","year":"2003","unstructured":"Delaiss\u00e9 JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech. 2003, 61:504-13. 10.1002\/jemt.10374","journal-title":"Microsc Res Tech"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.11.072","article-title":"Regulation of apoptosis in osteoclasts and osteoblastic cells","volume":"328","author":"Xing L","year":"2005","unstructured":"Xing L, Boyce BF. Regulation of apoptosis in osteoclasts and osteoblastic cells. Biochem Biophys Res Commun. 2005, 328:709-20. 10.1016\/j.bbrc.2004.11.072","journal-title":"Biochem Biophys Res Commun"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2013.215","article-title":"Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit","volume":"3","author":"Sims NA","year":"2014","unstructured":"Sims NA, Martin TJ. Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. Bonekey Rep. 2014, 3:481. 10.1038\/bonekey.2013.215","journal-title":"Bonekey Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650090311","article-title":"Deposition of cement at reversal lines in rat femoral bone","volume":"9","author":"Zhou H","year":"1994","unstructured":"Zhou H, Chernecky R, Davies JE. Deposition of cement at reversal lines in rat femoral bone. J Bone Miner Res. 1994, 9:367-74. 10.1002\/jbmr.5650090311","journal-title":"J Bone Miner Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.5.3204","article-title":"Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism","volume":"78","author":"Howard GA","year":"1981","unstructured":"Howard GA, Bottemiller BL, Turner RT, Rader JI, Baylink DJ. Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism. Proc Natl Acad Sci U S A. 1981, 78:3204-8. 10.1073\/pnas.78.5.3204","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald LF","year":"2011","unstructured":"Bonewald LF. The amazing osteocyte. J Bone Miner Res. 2011, 26:229-38. 10.1002\/jbmr.320","journal-title":"J Bone Miner Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1941.02820220007002","article-title":"Postmenopausal osteoporosis: its clinical features","volume":"116","author":"Albright F","year":"1941","unstructured":"Albright F, Smith PH, Richardson AM. Postmenopausal osteoporosis: its clinical features. JAMA. 1941, 116:2465-74. 10.1001\/jama.1941.02820220007002","journal-title":"JAMA"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650050402","article-title":"Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels","volume":"5","author":"Eriksen EF","year":"1990","unstructured":"Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res. 1990, 5:311-9. 10.1002\/jbmr.5650050402","journal-title":"J Bone Miner Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis","volume":"11","author":"Garnero P","year":"1996","unstructured":"Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996, 11:337-49. 10.1002\/jbmr.5650110307","journal-title":"J Bone Miner Res"},{"key":"ref36","article-title":"Menopausal changes in bone remodeling","volume":"92","author":"Heaney RP","year":"1978","unstructured":"Heaney RP, Recker RR, Saville PD. Menopausal changes in bone remodeling. J Lab Clin Med. 1978, 92:964-70.","journal-title":"J Lab Clin Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz LG","year":"2005","unstructured":"Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005, 115:3318-25. 10.1172\/JCI27071","journal-title":"J Clin Invest"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.13.4616","article-title":"Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis","volume":"84","author":"Pacifici R","year":"1987","unstructured":"Pacifici R, Rifas L, Teitelbaum S, et al.. Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci U S A. 1987, 84:4616-20. 10.1073\/pnas.84.13.4616","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.12.5134","article-title":"Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells","volume":"88","author":"Pacifici R","year":"1991","unstructured":"Pacifici R, Brown C, Puscheck E, et al.. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci U S A. 1991, 88:5134-8. 10.1073\/pnas.88.12.5134","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1126\/science.3164526","article-title":"Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells","volume":"241","author":"Komm BS","year":"1988","unstructured":"Komm BS, Terpening CM, Benz DJ, et al.. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science. 1988, 241:81-4. 10.1126\/science.3164526","journal-title":"Science"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.7.4858","article-title":"Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts","volume":"275","author":"Azuma Y","year":"2000","unstructured":"Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem. 2000, 275:4858-64. 10.1074\/jbc.275.7.4858","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.2.275","article-title":"Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction","volume":"191","author":"Kobayashi K","year":"2000","unstructured":"Kobayashi K, Takahashi N, Jimi E, et al.. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction. J Exp Med. 2000, 191:275-86. 10.1084\/jem.191.2.275","journal-title":"J Exp Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11176","article-title":"TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam J","year":"2000","unstructured":"Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000, 106:1481-8. 10.1172\/JCI11176","journal-title":"J Clin Invest"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.0301233","article-title":"RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis","volume":"19","author":"Li P","year":"2004","unstructured":"Li P, Schwarz EM, O'Keefe RJ, Ma L, Boyce BF, Xing L. RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. J Bone Miner Res. 2004, 19:207-13. 10.1359\/JBMR.0301233","journal-title":"J Bone Miner Res"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11066","article-title":"Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha","volume":"106","author":"Cenci S","year":"2000","unstructured":"Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest. 2000, 106:1229-37. 10.1172\/JCI11066","journal-title":"J Clin Invest"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115668","article-title":"17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens","volume":"89","author":"Girasole G","year":"1992","unstructured":"Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest. 1992, 89:883-91. 10.1172\/JCI115668","journal-title":"J Clin Invest"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura T","year":"2007","unstructured":"Nakamura T, Imai Y, Matsumoto T, et al.. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell. 2007, 130:811-23. 10.1016\/j.cell.2007.07.025","journal-title":"Cell"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0296","article-title":"Osteoclast apoptosis: the role of Fas in vivo and in vitro","volume":"144","author":"Wu X","year":"2003","unstructured":"Wu X, McKenna MA, Feng X, Nagy TR, McDonald JM. Osteoclast apoptosis: the role of Fas in vivo and in vitro. Endocrinology. 2003, 144:5545-55. 10.1210\/en.2003-0296","journal-title":"Endocrinology"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet WS","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, et al.. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997, 89:309-19. 10.1016\/s0092-8674(00)80209-3","journal-title":"Cell"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)81569-x","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey DL","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, et al.. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998, 93:165-76. 10.1016\/s0092-8674(00)81569-x","journal-title":"Cell"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.6.8220","article-title":"17beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha","volume":"142","author":"Saika M","year":"2001","unstructured":"Saika M, Inoue D, Kido S, Matsumoto T. 17beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha. Endocrinology. 2001, 142:2205-12. 10.1210\/endo.142.6.8220","journal-title":"Endocrinology"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.suppl_2.ii32","article-title":"Role of RANKL and RANK in bone loss and arthritis","volume":"61","author":"Jones DH","year":"2002","unstructured":"Jones DH, Kong YY, Penninger JM. Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis. 2002, 61:ii32-9. 10.1136\/ard.61.suppl_2.ii32","journal-title":"Ann Rheum Dis"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda T","year":"1999","unstructured":"Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999, 20:345-57. 10.1210\/edrv.20.3.0367","journal-title":"Endocr Rev"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda H","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, et al.. Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci U S A. 1998, 95:3597-602. 10.1073\/pnas.95.7.3597","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi G","year":"2003","unstructured":"Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest. 2003, 111:1221-30. 10.1172\/JCI17215","journal-title":"J Clin Invest"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.5152\/balkanmedj.2014.13265","article-title":"Fracture history in osteoporosis: risk factors and its effect on quality of life","volume":"31","author":"Kuru P","year":"2014","unstructured":"Kuru P, Aky\u00fcz G, Cer\u015fit HP, et al.. Fracture history in osteoporosis: risk factors and its effect on quality of life. Balkan Med J. 2014, 31:295-301. 10.5152\/balkanmedj.2014.13265","journal-title":"Balkan Med J"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-011-1863-5","article-title":"Defining ethnic and racial differences in osteoporosis and fragility fractures","volume":"469","author":"Cauley JA","year":"2011","unstructured":"Cauley JA. Defining ethnic and racial differences in osteoporosis and fragility fractures. Clin Orthop Relat Res. 2011, 469:1891-9. 10.1007\/s11999-011-1863-5","journal-title":"Clin Orthop Relat Res"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2019_413","article-title":"Genetic predisposition for osteoporosis and fractures in postmenopausal women","volume":"1211","author":"Mitek T","year":"2019","unstructured":"Mitek T, Nagraba \u0141, Deszczy\u0144ski J, Stolarczyk M, Kuchar E, Stolarczyk A. Genetic predisposition for osteoporosis and fractures in postmenopausal women. Adv Exp Med Biol. 2019, 1211:17-24. 10.1007\/5584_2019_413","journal-title":"Adv Exp Med Biol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2017.71.25-28","article-title":"Risk factors for osteoporosis in postmenopausal women","volume":"71","author":"Bijelic R","year":"2017","unstructured":"Bijelic R, Milicevic S, Balaban J. Risk factors for osteoporosis in postmenopausal women. Med Arch. 2017, 71:25-8. 10.5455\/medarh.2017.71.25-28","journal-title":"Med Arch"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90468-1","article-title":"Risk factors for postmenopausal osteoporosis","volume":"78","author":"Aloia JF","year":"1985","unstructured":"Aloia JF, Cohn SH, Vaswani A, Yeh JK, Yuen K, Ellis K. Risk factors for postmenopausal osteoporosis. Am J Med. 1985, 78:95-100. 10.1016\/0002-9343(85)90468-1","journal-title":"Am J Med"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1089\/biores.2016.0045","article-title":"Prevalence and risk factors of osteoporosis among Jordanian postmenopausal women attending the National Center for Diabetes, Endocrinology and Genetics in Jordan","volume":"6","author":"Hyassat D","year":"2017","unstructured":"Hyassat D, Alyan T, Jaddou H, Ajlouni KM. Prevalence and risk factors of osteoporosis among Jordanian postmenopausal women attending the National Center for Diabetes, Endocrinology and Genetics in Jordan. Biores Open Access. 2017, 6:85-93. 10.1089\/biores.2016.0045","journal-title":"Biores Open Access"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajme.2016.03.007","article-title":"Nutritional risk factors for postmenopausal osteoporosis","volume":"53","author":"Berriche O","year":"2017","unstructured":"Berriche O, Chiraz A, Othman RB, et al.. Nutritional risk factors for postmenopausal osteoporosis. Alexandria J Med. 2017, 53:187-92. 10.1016\/j.ajme.2016.03.007","journal-title":"Alexandria J Med"},{"key":"ref63","article-title":"Risk factors for osteoporosis and associated fractures","volume":"104 Suppl","author":"Kelsey JL","year":"1989","unstructured":"Kelsey JL. Risk factors for osteoporosis and associated fractures. Public Health Rep. 1989, 104 Suppl:14-20.","journal-title":"Public Health Rep"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-020-05294-3","article-title":"Determinants of imminent fracture risk in postmenopausal women with osteoporosis","volume":"31","author":"Barron RL","year":"2020","unstructured":"Barron RL, Oster G, Grauer A, Crittenden DB, Weycker D. Determinants of imminent fracture risk in postmenopausal women with osteoporosis. Osteoporos Int. 2020, 31:2103-11. 10.1007\/s00198-020-05294-3","journal-title":"Osteoporos Int"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.1998.11720768","article-title":"Osteoporosis during pregnancy and its management","volume":"107","author":"Smith R","year":"1998","unstructured":"Smith R, Phillips AJ. Osteoporosis during pregnancy and its management. Scand J Rheumatol Suppl. 1998, 107:66-7. 10.1080\/03009742.1998.11720768","journal-title":"Scand J Rheumatol Suppl"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis JA","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019, 30:3-44. 10.1007\/s00198-018-4704-5","journal-title":"Osteoporos Int"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-018-00512-x","article-title":"Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"104","author":"Kanis JA","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY. Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Calcif Tissue Int. 2019, 104:235-8. 10.1007\/s00223-018-00512-x","journal-title":"Calcif Tissue Int"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-2030-x","article-title":"Osteoporosis in young adults: pathophysiology, diagnosis, and management","volume":"23","author":"Ferrari S","year":"2012","unstructured":"Ferrari S, Bianchi ML, Eisman JA, et al.. Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int. 2012, 23:2735-48. 10.1007\/s00198-012-2030-x","journal-title":"Osteoporos Int"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3390\/nu10121930","article-title":"Calcium intake in bone health: a focus on calcium-rich mineral waters","volume":"10","author":"Vannucci L","year":"2018","unstructured":"Vannucci L, Fossi C, Quattrini S, et al.. Calcium intake in bone health: a focus on calcium-rich mineral waters. Nutrients. 2018, 10:1930. 10.3390\/nu10121930","journal-title":"Nutrients"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-013-0391-2","article-title":"Adequate dietary protein is associated with better physical performance among post-menopausal women 60-90 years","volume":"18","author":"Gregorio L","year":"2014","unstructured":"Gregorio L, Brindisi J, Kleppinger A, et al.. Adequate dietary protein is associated with better physical performance among post-menopausal women 60-90 years. J Nutr Health Aging. 2014, 18:155-60. 10.1007\/s12603-013-0391-2","journal-title":"J Nutr Health Aging"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1038\/srep25662","article-title":"Adherence to the Mediterranean diet is associated with a higher BMD in middle-aged and elderly Chinese","volume":"6","author":"Chen GD","year":"2016","unstructured":"Chen GD, Dong XW, Zhu YY, Tian HY, He J, Chen YM. Adherence to the Mediterranean diet is associated with a higher BMD in middle-aged and elderly Chinese. Sci Rep. 2016, 6:25662. 10.1038\/srep25662","journal-title":"Sci Rep"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000100","article-title":"Effects of walking on the preservation of bone mineral density in perimenopausal and postmenopausal women: a systematic review and meta-analysis","volume":"20","author":"Ma D","year":"2013","unstructured":"Ma D, Wu L, He Z. Effects of walking on the preservation of bone mineral density in perimenopausal and postmenopausal women: a systematic review and meta-analysis. Menopause. 2013, 20:1216-26. 10.1097\/GME.0000000000000100","journal-title":"Menopause"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2008.05.012","article-title":"Meta-analysis of walking for preservation of bone mineral density in postmenopausal women","volume":"43","author":"Martyn-St James M","year":"2008","unstructured":"Martyn-St James M, Carroll S. Meta-analysis of walking for preservation of bone mineral density in postmenopausal women. Bone. 2008, 43:521-31. 10.1016\/j.bone.2008.05.012","journal-title":"Bone"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-016-0343-1","article-title":"The effect of brisk walking on postural stability, bone mineral density, body weight and composition in women over 50\u00a0years with a sedentary occupation: a randomized controlled trial","volume":"16","author":"G\u00e1ba A","year":"2016","unstructured":"G\u00e1ba A, Cuberek R, Svoboda Z, Chmel\u00edk F, Pelclov\u00e1 J, Lehnert M, Fr\u00f6mel K. The effect of brisk walking on postural stability, bone mineral density, body weight and composition in women over 50\u00a0years with a sedentary occupation: a randomized controlled trial. BMC Womens Health. 2016, 16:63. 10.1186\/s12905-016-0343-1","journal-title":"BMC Womens Health"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2388-2","article-title":"Effects of short-term aerobic exercise with and without external loading on bone metabolism and balance in postmenopausal women with osteoporosis","volume":"33","author":"Roghani T","year":"2013","unstructured":"Roghani T, Torkaman G, Movasseghe S, Hedayati M, Goosheh B, Bayat N. Effects of short-term aerobic exercise with and without external loading on bone metabolism and balance in postmenopausal women with osteoporosis. Rheumatol Int. 2013, 33:291-8. 10.1007\/s00296-012-2388-2","journal-title":"Rheumatol Int"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3034-0","article-title":"The effects of differing resistance training modes on the preservation of bone mineral density in postmenopausal women: a meta-analysis","volume":"26","author":"Zhao R","year":"2015","unstructured":"Zhao R, Zhao M, Xu Z. The effects of differing resistance training modes on the preservation of bone mineral density in postmenopausal women: a meta-analysis. Osteoporos Int. 2015, 26:1605-18. 10.1007\/s00198-015-3034-0","journal-title":"Osteoporos Int"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3263-2","article-title":"Heavy resistance training is safe and improves bone, function, and stature in postmenopausal women with low to very low bone mass: novel early findings from the LIFTMOR trial","volume":"26","author":"Watson SL","year":"2015","unstructured":"Watson SL, Weeks BK, Weis LJ, Horan SA, Beck BR. Heavy resistance training is safe and improves bone, function, and stature in postmenopausal women with low to very low bone mass: novel early findings from the LIFTMOR trial. Osteoporos Int. 2015, 26:2889-94. 10.1007\/s00198-015-3263-2","journal-title":"Osteoporos Int"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6131.171717","article-title":"Effects of Yogasanas on osteoporosis in postmenopausal women","volume":"9","author":"Motorwala ZS","year":"2016","unstructured":"Motorwala ZS, Kolke S, Panchal PY, Bedekar NS, Sancheti PK, Shyam A. Effects of Yogasanas on osteoporosis in postmenopausal women. Int J Yoga. 2016, 9:44-8. 10.4103\/0973-6131.171717","journal-title":"Int J Yoga"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2014.0397","article-title":"Suggestions for adapting Yoga to the needs of older adults with osteoporosis","volume":"22","author":"McArthur C","year":"2016","unstructured":"McArthur C, Laprade J, Giangregorio LM. Suggestions for adapting Yoga to the needs of older adults with osteoporosis. J Altern Complement Med. 2016, 22:223-6. 10.1089\/acm.2014.0397","journal-title":"J Altern Complement Med"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3390\/nu6020729","article-title":"Vitamin D deficiency in India: prevalence, causalities and interventions","volume":"6","author":"Ritu G","year":"2014","unstructured":"Ritu G, Gupta A. Vitamin D deficiency in India: prevalence, causalities and interventions. Nutrients. 2014, 6:729-75. 10.3390\/nu6020729","journal-title":"Nutrients"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007146.pub3","article-title":"Interventions for preventing falls in older people living in the community","volume":"3","author":"Gillespie LD","year":"2012","unstructured":"Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, Lamb SE. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012, 3:CD007146. 10.1002\/14651858.CD007146.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref82","unstructured":"FRAX score. calculator, meaning, and more. (2022). Accessed: August 26, 2022: https:\/\/www.healthline.com\/health\/frax-score."},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2010.2294","article-title":"The Fracture Risk Assessment Tool (FRAX\u00ae): applications in clinical practice","volume":"20","author":"Watts NB","year":"2011","unstructured":"Watts NB. The Fracture Risk Assessment Tool (FRAX\u00ae): applications in clinical practice. J Womens Health (Larchmt). 2011, 20:525-31. 10.1089\/jwh.2010.2294","journal-title":"J Womens Health (Larchmt)"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-010-0032-1","article-title":"The utility and limitations of FRAX: a US perspective","volume":"8","author":"Silverman SL","year":"2010","unstructured":"Silverman SL, Calderon AD. The utility and limitations of FRAX: a US perspective. Curr Osteoporos Rep. 2010, 8:192-7. 10.1007\/s11914-010-0032-1","journal-title":"Curr Osteoporos Rep"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman F","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014, 25:2359-81. 10.1007\/s00198-014-2794-2","journal-title":"Osteoporos Int"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis JA","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008, 19:385-97. 10.1007\/s00198-007-0543-5","journal-title":"Osteoporos Int"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.090402","article-title":"FRAX facts","volume":"24","author":"Watts NB","year":"2009","unstructured":"Watts NB, Ettinger B, LeBoff MS. FRAX facts. J Bone Miner Res. 2009, 24:975-9. 10.1359\/jbmr.090402","journal-title":"J Bone Miner Res"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2009.01.373","article-title":"FRAX and its applications to clinical practice","volume":"44","author":"Kanis JA","year":"2009","unstructured":"Kanis JA, Oden A, Johansson H, Borgstr\u00f6m F, Str\u00f6m O, McCloskey E. FRAX and its applications to clinical practice. Bone. 2009, 44:734-43. 10.1016\/j.bone.2009.01.373","journal-title":"Bone"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice. Postmenopausal osteoporosis","volume":"374","author":"Black DM","year":"2016","unstructured":"Black DM, Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med. 2016, 374:254-62. 10.1056\/NEJMcp1513724","journal-title":"N Engl J Med"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.7.872","article-title":"Postmenopausal hormone replacement therapy: scientific review","volume":"288","author":"Nelson HD","year":"2002","unstructured":"Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: scientific review. JAMA. 2002, 288:872-81. 10.1001\/jama.288.7.872","journal-title":"JAMA"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000921","article-title":"The 2017 hormone therapy position statement of The North American Menopause Society","volume":"24","author":"The NAMS 2017 Hormone Therapy Position Statement Advisory Panel","year":"2017","unstructured":"The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017, 24:728-53. 10.1097\/GME.0000000000000921","journal-title":"Menopause"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001100","article-title":"Concern about US Preventive Services Task Force recommendation on hormone therapy for the primary prevention of chronic conditions in postmenopausal women","volume":"25","author":"Pinkerton JV","year":"2018","unstructured":"Pinkerton JV, Kaunitz AM, Manson JE. Concern about US Preventive Services Task Force recommendation on hormone therapy for the primary prevention of chronic conditions in postmenopausal women. Menopause. 2018, 25:476. 10.1097\/GME.0000000000001100","journal-title":"Menopause"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2021036","article-title":"Menopausal osteoporosis: screening, prevention and treatment","volume":"62","author":"Yong EL","year":"2021","unstructured":"Yong EL, Logan S. Menopausal osteoporosis: screening, prevention and treatment. Singapore Med J. 2021, 62:159-66. 10.11622\/smedj.2021036","journal-title":"Singapore Med J"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1210\/er.2001-5002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women","volume":"23","author":"Wells G","year":"2002","unstructured":"Wells G, Tugwell P, Shea B, et al.. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev. 2002, 23:529-39. 10.1210\/er.2001-5002","journal-title":"Endocr Rev"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.5114\/pm.2014.44996","article-title":"Hormone replacement therapy and the prevention of postmenopausal osteoporosis","volume":"13","author":"Gambacciani M","year":"2014","unstructured":"Gambacciani M, Levancini M. Hormone replacement therapy and the prevention of postmenopausal osteoporosis. Prz Menopauzalny. 2014, 13:213-20. 10.5114\/pm.2014.44996","journal-title":"Prz Menopauzalny"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black DM","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, et al.. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007, 356:1809-22. 10.1056\/NEJMoa067312","journal-title":"N Engl J Med"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black DM","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB, et al.. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996, 348:1535-41. 10.1016\/s0140-6736(96)07088-2","journal-title":"Lancet"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings SR","year":"1998","unstructured":"Cummings SR, Black DM, Thompson DE, et al.. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998, 280:2077-82. 10.1001\/jama.280.24.2077","journal-title":"JAMA"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut CH 3rd","year":"2004","unstructured":"Chesnut CH 3rd, Skag A, Christiansen C, et al.. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004, 19:1241-9. 10.1359\/JBMR.040325","journal-title":"J Bone Miner Res"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1185\/030079908x253717","article-title":"Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies","volume":"24","author":"Harris ST","year":"2008","unstructured":"Harris ST, Blumentals WA, Miller PD. Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies. Curr Med Res Opin. 2008, 24:237-45. 10.1185\/030079908x253717","journal-title":"Curr Med Res Opin"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group","volume":"11","author":"Reginster J","year":"2000","unstructured":"Reginster J, Minne HW, Sorensen OH, et al.. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int. 2000, 11:83-91. 10.1007\/s001980050010","journal-title":"Osteoporos Int"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley DA","year":"2012","unstructured":"Hanley DA, Adachi JD, Bell A, Brown V. Denosumab: mechanism of action and clinical outcomes. Int J Clin Pract. 2012, 66:1139-46. 10.1111\/ijcp.12022","journal-title":"Int J Clin Pract"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings SR","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, et al.. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009, 361:756-65. 10.1056\/NEJMoa0809493","journal-title":"N Engl J Med"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger B","year":"1999","unstructured":"Ettinger B, Black DM, Mitlak BH, et al.. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999, 282:637-45. 10.1001\/jama.282.7.637","journal-title":"JAMA"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel VG","year":"2006","unstructured":"Vogel VG, Costantino JP, Wickerham DL, et al.. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006, 295:2727-41. 10.1001\/jama.295.23.joc60074","journal-title":"JAMA"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.02.093","article-title":"Efficacy of tissue-selective estrogen complex of bazedoxifene\/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women","volume":"92","author":"Lindsay R","year":"2009","unstructured":"Lindsay R, Gallagher JC, Kagan R, Pickar JH, Constantine G. Efficacy of tissue-selective estrogen complex of bazedoxifene\/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women. Fertil Steril. 2009, 92:1045-52. 10.1016\/j.fertnstert.2009.02.093","journal-title":"Fertil Steril"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013509233","article-title":"Salmon calcitonin use and associated cancer risk","volume":"47","author":"Overman RA","year":"2013","unstructured":"Overman RA, Borse M, Gourlay ML. Salmon calcitonin use and associated cancer risk. Ann Pharmacother. 2013, 47:1675-84. 10.1177\/1060028013509233","journal-title":"Ann Pharmacother"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla S","year":"2017","unstructured":"Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 2017, 5:898-907. 10.1016\/S2213-8587(17)30188-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1934.02750160010003","article-title":"Hyperparathyroidism: a common and polymorphic condition as illustrated by seventeen proved cases from one clinic","volume":"102","author":"Albright F","year":"1934","unstructured":"Albright F, Aub JC, Bauer W. Hyperparathyroidism: a common and polymorphic condition as illustrated by seventeen proved cases from one clinic. JAMA. 1934, 102:1276-87. 10.1001\/jama.1934.02750160010003","journal-title":"JAMA"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(76)92216-9","article-title":"Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis","volume":"1","author":"Reeve J","year":"1976","unstructured":"Reeve J, Hesp R, Williams D, et al.. Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet. 1976, 1:1035-8. 10.1016\/s0140-6736(76)92216-9","journal-title":"Lancet"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer RM","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, et al.. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001, 344:1434-41. 10.1056\/NEJM200105103441904","journal-title":"N Engl J Med"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.2147\/cia.s241","article-title":"Teriparatide in the management of osteoporosis","volume":"2","author":"Bodenner D","year":"2007","unstructured":"Bodenner D, Redman C, Riggs A. Teriparatide in the management of osteoporosis. Clin Interv Aging. 2007, 2:499-507. 10.2147\/cia.s241","journal-title":"Clin Interv Aging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/114102-postmenopausal-osteoporosis-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:38:52Z","timestamp":1707489532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/114102-postmenopausal-osteoporosis-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":112,"URL":"https:\/\/doi.org\/10.7759\/cureus.29367","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,20]]}}}